Clinical Trial Update: Combine GELOX With Concurrent Radiation Therapy for Patients With Stage IE/IIE ENKTL [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the GELOX chemotherapy regimen with concurrent radiation therapy for Stage IE/IIE Extranodal NK/T-cell lymphoma (ENKTL).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma Nasal Type

Drugs mentioned

• Gemcitabine (Gemzar) (gemcitabine)
• L-Asparaginase (Elspar) (L-asparaginase)
• Oxaliplatin (Eloxatin) (oxaliplatin)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Lymphoma, Extranodal NK-T-Cell | Phase 2 | Status: UNKNOWN